VALIANT® Captivia VAMF3228C150TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VAMF3228C150TU VALCAP TAPER · Class 3 · Implant
All models of VALIANT Captivia (95)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 1
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00643169400139), received between Jan 28, 2019 and Jun 16, 2025 — classified as 1 death, 3 injuries.
The most frequently reported specific device problem is “Leak/Splash” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
- Leak/Splash2
Patient problems
- Hematoma1
- Insufficient Information1
- Intimal Dissection1
- Pain1
- Paralysis1
- Rupture1
- Unspecified Infection1
- Vascular Dissection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
DeathJun 16, 2025Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem
A VALIANT CAPTIVIA STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A PAU. IT WAS REPORTED THAT THE PATIENT RETURNED FIVE DAYS LATER WITH CONCERNS FOR A POSSIBLE RUPTURE. IT WAS BELIEVED AFTER A CT SCAN WAS PERFORMED, THE AORTA MAY BE MYCOTIC AND WOULD NOW BE RELINED WITH A NON-MEDTRONIC STENT GRAFT. THE PATIENT THEN PASSED AWAY ON AN UNKNOWN DATE. THE CAUSE OF DEATH IS UNKNOWN BUT IT WAS SAID THE PATIENT WAS VERY SICK WITH OTHER CO MORBIDITIES AND HAD PRE-EXISTING ADVANCED UNKNOWN TYPE OF CANCER. A POSSIBLE RUPTURE AND POSSIBLE INFECTION WERE MENTIONED AS WELL AS CONCERNS OF POSSIBLE MYCOTIC INFECTION DETERIORATING THE VALIANT CAPTIVIA GRAFT.
Patient problems: Insufficient Information; Rupture; Unspecified Infection
MAUDE report 22210982 ↗InjuryAug 10, 2022Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem
A VALIANT CAPTIVIA STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC DISSECTION . IT WAS REPORTED THE PATIENT PRESENTED EMERGENTLY TO ER WITH CHEST PAIN . A CT PERFORMED SHOWED THE PRESENCE OF A RETROGRADE TYPE A DISSECTION. THE PATIENT HAD OPEN ARCH SURGERY AS TREATMENT OF THE SAME DATE AND THE EVENT RESOLVED. PER THE PHYSICIAN , IT APPEARED THE RTAD ORIGINATED AT A POINT OF CONTACT WHERE A SUPRARENAL STENT OF THE STENT GRAFT MADE CONTACT WITH THE AORTIC ARCH AND MAY BE THE CAUSE. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS FINE.
Patient problems: Pain; Vascular Dissection
MAUDE report 15202367 ↗InjuryMay 30, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
VALIANT NAVION STENT GRAFTS WERE IMPLANTED FOR THE ENDOVASCULAR TREATMENT OF A 200MM THORACIC AORTIC DISSECTION. IT WAS REPORTED ON AN UNKNOWN DATE A FEW DAYS AFTER THE INDEX PROCEDURE AND SPINE DRAIN REMOVAL THE PATIENT PRESENTED WITH PARALYSIS. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT MAY BE DUE TO A POSSIBLE HEMATOMA AT THE SPINAL DRAIN SITE. NO ADDITIONAL CLINICAL SEQUALAE WAS PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Hematoma; Paralysis
MAUDE report 14540007 ↗InjuryJan 28, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A VALIANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE THORACIC ENDOVASCULAR TREATMENT OF A 300 MM ACUTE TYPE B DISSECTION THAT STARTED JUST BELOW THE LEFT SUBCLAVIAN ARTERY. DURING THE INDEX PROCEDURE VALIANT STENT GRAFT VAMF3228C150 WAS IMPLANTED AT THE PATIENTS LEFT CAROTID AFTER PERFORMING A LEFT CAROTID TO LEFT SUBCLAVIAN BYPASS. IT WAS REPORTED THE GRAFT WAS PLACED WITHOUT INCIDENCE AND AN ADDITIONAL VALIANT STENT GRAFT WAS PLACED DISTAL TO THE CELIAC TRUNK. IT WAS REPORTED THAT FINAL ANGIOGRAM SHOWED THE PATIENT HAD A TYPE A RETROGRADE DISSECTION THAT ALSO EXTENDED INTO THE INNOMINATE ARTERY. IT WAS DECIDED TO REPAIR THE ASCENDING DISSECTION. THE BARE SPRINGS OF THE VALIANT STENT GRAFT WERE REMOVED WITH WIRE CUTTERS AND A NON-MDT SYNTHETIC GRAFT WAS SEWN DIRECTLY TO THE VALIANT STENT GRAFT. THE INNOMINATE AND RIGHT CAROTID ARTERIES WERE ALSO RECONSTRUCTED. THE EVENT WAS REPORTED TO BE RESOLVED. AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT WAS POSSIBLY CAUSED BY THE PROXIMAL BARE STENTS OF THE STENT GRAFT. IT WAS REPORTED THE BARE SPRING WAS IN THE INNOMINATE ARTERY AND MAY HAVE CAUSED THE DISSECTION. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS F
Patient problems: Intimal Dissection
MAUDE report 8280662 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page